The global Home Infusion Therapy market size is projected to reach US$ 29640 million by 2027, from US$ 19850 million in 2020, at a CAGR of 5.8% during 2021-2027. The increasing geriatric population with decreased mobility profile along with the rising preference for home care are driving the home infusion therapy market.
The increasing preference for homecare facilities, combined with an increase in the geriatric population, will propel the adoption of home infusion treatment services. The growing popularity of home care facilities is expected to boost demand for the home infusion therapy market. Furthermore, the growing need to minimize the length of inpatient stays in hospitals is predicted to drive home infusion therapy market growth.
The research report studies the Home Infusion Therapy market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
Based on application, the anti-infective application segment is expected to be the most lucrative segment during the forecast period. The segment's growth is attributed to the administration of medication such as antifungals and antibiotics that are used in a large number of procedures. This will generate significant demand for anti-infective therapy, thereby fuelling the market growth.
Based on region, North America is expected to be the most lucrative. The U.S. dominated the North American home infusion therapy market. One of the key factors driving the market growth across North America is the presence of major industry players in the region. The rising frequency of chronic diseases will have a significant impact on the size of the regional market. Treatment costs, new product launches, and technology developments are expected to boost regional growth.
The global Home Infusion Therapy Market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Home Infusion Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and Application for the period 2016-2027.
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
Report Metric |
Details |
Report Name |
Home Infusion Therapy Market |
The market size in 2020 |
USD 19850 Million |
The revenue forecast in 2027 |
USD 29640 Million |
Growth Rate |
CAGR of 5.8% from 2021 to 2027 |
Market size available for years |
2021-2027 |
Forecast units |
Value (USD) |
Segments covered |
Type, End-User, Offerings, and Region |
Report coverage |
Revenue & volume forecast, company share, competitive landscape, growth factors, and trends |
Geographic regions covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Ans. The global Home Infusion Therapy market size is projected to reach US$ 29640 million by 2027, from US$ 19850 million in 2020, at a CAGR of 5.8% during 2021-2027.
Ans. The increasing preference for homecare facilities, combined with an increase in the geriatric population, will propel the adoption of home infusion treatment services. The growing popularity of home care facilities is expected to boost demand for the home infusion therapy market.
Ans. Based on region, North America is expected to be the most lucrative. The U.S. dominated the North American home infusion therapy market.
Ans. Based on application, the anti-infective application segment is expected to be the most lucrative segment during the forecast period.
Ans. The forecast period for the home infusion therapy market is 2021 to 2027
Ans. The major vendors operating in the home infusion therapy market include Baxter, Caesarea Medical Electronics, B.Braun Melsungen AG, CareFusion Corporation, ICU Medical,Inc., Fresenius Kabi AG, JMS Co.Ltd, Terumo Corporation, Smiths Medica.
List of Tables & Figures
$3900
$5850
$7800
HAVE A QUERY?
OUR CUSTOMER
SIMILAR REPORTS
Add to Cart
Add to Cart
Add to Cart
Add to Cart